Cancer Genetics Inc. (Nasdaq: CGIX) is buying BioServe India for $1.9 million.

The acquisition is meant to help the Rutherford, N.J.-based buyer capitalize on the growing clinical diagnostics market in the India and Asian markets.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.